Publications by authors named "Kosuke Ieiri"

Claim this Profile
T
TFE3-immunopositive papillary renal cell carcinoma: A clinicopathological, immunohistochemical, and genetic study.
Dai Takamatsu, Kenichi Kohashi, Daisuke Kiyozawa, Fumio Kinoshita, Kosuke Ieiri

Pathol Res Pract· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Lower Tract Urinary Symptoms in Clinically Regional Lymph Node-positive Prostate Cancer.
Leandro Blas, Kosuke Ieiri, Masaki Shiota, Shohei Nagakawa, Shigehiro Tsukahara

Anticancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate Cancer.
Leandro Blas, Masaki Shiota, Shigetomo Yamada, Kosuke Ieiri, Shohei Nagakawa

Anticancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognosis and the impact of radiotherapy in clinically regional lymph node-positive prostate cancer: Which patients are candidates for local therapy with radiation?
Kosuke Ieiri, Masaki Shiota, Eiji Kashiwagi, Ario Takeuchi, Ryosuke Takahashi

Urol Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of changing therapy from gemcitabine and cisplatin chemotherapy based on real-world data of advanced urothelial carcinoma.
Nobuki Furubayashi, Takahito Negishi, Dai Takamatsu, Kosuke Ieiri, Tomohiro Inoue

Oncol Lett· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse of aseptic meningitis induced by ipilimumab and nivolumab therapy for metastatic renal cell carcinoma: A case report.
Dai Takamatsu, Nobuki Furubayashi, Takahito Negishi, Kosuke Ieiri, Tomohiro Inoue

Mol Clin Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis